SAMUEL A ALLEN D.O.
Prescription History 1306861414
Internal Medicine - Pulmonary Disease in Troy, MI
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SAMUEL A ALLEN D.O., an active Pulmonary Disease specialist practicing in Troy, MI. Our medical registry currently tracks 21 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 987 documented patient claims. Among these therapy options, the most frequently utilized medication is Opsumit, which accounts for 187 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MI PrescribersVs. MI Avg |
|---|---|---|---|
| OpsumitMacitentan | 187 | $12,502.47 | ▲ More than typical |
About Opsumit: Macitentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, which helps decrease the blood pressure in the lungs, and reduces the risk of worsening of symptoms and hospital stays due to the disease. In 2023, this provider wrote 187 Medicare prescriptions for Opsumit, about 2.9 times the volume of the typical Michigan prescriber of this medication (65). Medicare paid an average of $12,502.47 per fill, versus $11,444.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 187 30-Day Fills standardized to 30-day supplies 5,520 Days of Medication total across all patients in 2023 | |||
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 153 | $1,329.61 | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 153 Medicare prescriptions for Trelegy Ellipta, about 3.1 times the volume of the typical Michigan prescriber of this medication (49). Medicare paid an average of $1,329.61 per fill, versus $868.62 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 325 30-Day Fills standardized to 30-day supplies 9,750 Days of Medication total across all patients in 2023 | |||
| Tadalafil | 108 | $1,266.38 | ▲ More than typical |
About Tadalafil: Tadalafil is used to treat high blood pressure in the lungs (pulmonary hypertension). Show more ▾ It works by relaxing and widening the blood vessels in your lungs which allows the blood to flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION. In 2023, this provider wrote 108 Medicare prescriptions for Tadalafil, about 4.3 times the volume of the typical Michigan prescriber of this medication (25). Medicare paid an average of $1,266.38 per fill, versus $714.83 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 108 30-Day Fills standardized to 30-day supplies 3,210 Days of Medication total across all patients in 2023 | |||
| Prednisone | 98 | $4.10▼ below MI avg | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 98 Medicare prescriptions for Prednisone, about 2.2 times the volume of the typical Michigan prescriber of this medication (44). Medicare paid an average of $4.10 per fill, versus $5.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 134 30-Day Fills standardized to 30-day supplies 2,365 Days of Medication total across all patients in 2023 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $57.72 | ≈ Typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 72 Medicare prescriptions for Albuterol Sulfate Hfa, about 1.2 times the volume of the typical Michigan prescriber of this medication (58). Medicare paid an average of $57.72 per fill, versus $51.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 98.8 30-Day Fills standardized to 30-day supplies 2,676 Days of Medication total across all patients in 2023 | |||
| Tyvaso DpiTreprostinil | 72 | $22,581.55▼ below MI avg | ▲ More than typical |
About Tyvaso Dpi: This medication is used to treat a type of high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ Treprostinil helps to improve symptoms such as shortness of breath and tiredness. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators. In 2023, this provider wrote 72 Medicare prescriptions for Tyvaso Dpi, about 1.8 times the volume of the typical Michigan prescriber of this medication (40). Medicare paid an average of $22,581.55 per fill, versus $23,592.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 72 30-Day Fills standardized to 30-day supplies 2,016 Days of Medication total across all patients in 2023 | |||
| CefuroximeCefuroxime Axetil | 35 | $16.59▼ below MI avg | ▲ More than typical |
About Cefuroxime: Cefuroxime is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A cephalosporin antibiotic. In 2023, this provider wrote 35 Medicare prescriptions for Cefuroxime, about 1.3 times the volume of the typical Michigan prescriber of this medication (26). Medicare paid an average of $16.59 per fill, versus $20.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 35 30-Day Fills standardized to 30-day supplies 289 Days of Medication total across all patients in 2023 | |||
| Ambrisentan | 34 | $2,419.03▼ below MI avg | ≈ Typical |
About Ambrisentan: Ambrisentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the lungs, slow the worsening of symptoms, and improve your ability to exercise. In 2023, this provider wrote 34 Medicare prescriptions for Ambrisentan, about the same volume as the typical Michigan prescriber of this medication (35). Medicare paid an average of $2,419.03 per fill, versus $4,589.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| AdempasRiociguat | 28 | $13,158.90 | ▼ Less than typical |
About Adempas: Riociguat is used to treat high blood pressure in the lungs (pulmonary hypertension). Show more ▾ It can also be used to treat a certain type of high blood pressure in the lungs caused by blood clots (chronic thromboembolic pulmonary hypertension) when surgery has not been fully successful or is impossible. Riociguat works by relaxing and widening the blood vessels in your lungs so blood can flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. In 2023, this provider wrote 28 Medicare prescriptions for Adempas, about half the volume of the typical Michigan prescriber of this medication (47). Medicare paid an average of $13,158.90 per fill, versus $12,526.31 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2023 | |||
| Montelukast Sodium | 21 | $8.53▼ below MI avg | ▼ Less than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. In 2023, this provider wrote 21 Medicare prescriptions for Montelukast Sodium, about half the volume of the typical Michigan prescriber of this medication (50). Medicare paid an average of $8.53 per fill, versus $19.21 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,163 Days of Medication total across all patients in 2023 | |||
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 21 | $76.66▼ below MI avg | ▲ More than typical |
About Levalbuterol Tartrate Hfa: Levalbuterol is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is a quick-relief drug. Levalbuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. This drug is not approved for use in children younger than 4 years due to increased risk of side effects (such as unusual fast breathing, worsening asthma). Ask your doctor or pharmacist for details. In 2023, this provider wrote 21 Medicare prescriptions for Levalbuterol Tartrate Hfa, about 1.3 times the volume of the typical Michigan prescriber of this medication (16). Medicare paid an average of $76.66 per fill, versus $79.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 27.1 30-Day Fills standardized to 30-day supplies 758 Days of Medication total across all patients in 2023 | |||
| LetairisAmbrisentan | 21 | $13,211.68 | ≈ Typical |
About Letairis: Ambrisentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the lungs, slow the worsening of symptoms, and improve your ability to exercise. In 2023, this provider wrote 21 Medicare prescriptions for Letairis, about the same volume as the typical Michigan prescriber of this medication (20). Medicare paid an average of $13,211.68 per fill, versus $11,738.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| Breo ElliptaFluticasone/Vilanterol | 20 | $640.56 | ▼ Less than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 20 Medicare prescriptions for Breo Ellipta, about 69% of the volume of the typical Michigan prescriber of this medication (29). Medicare paid an average of $640.56 per fill, versus $520.74 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| SymbicortBudesonide/Formoterol Fumarate | 19 | $627.15 | ▼ Less than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 19 Medicare prescriptions for Symbicort, about half the volume of the typical Michigan prescriber of this medication (33). Medicare paid an average of $627.15 per fill, versus $548.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| Doxycycline Hyclate | 19 | $5.21▼ below MI avg | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2023, this provider wrote 19 Medicare prescriptions for Doxycycline Hyclate, about 70% of the volume of the typical Michigan prescriber of this medication (27). Medicare paid an average of $5.21 per fill, versus $19.36 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 19 30-Day Fills standardized to 30-day supplies 133 Days of Medication total across all patients in 2023 | |||
| Bumetanide | 18 | $22.75▼ below MI avg | ▼ Less than typical |
About Bumetanide: Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. Bumetanide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A sulfamyl diuretic. In 2023, this provider wrote 18 Medicare prescriptions for Bumetanide, about half the volume of the typical Michigan prescriber of this medication (32). Medicare paid an average of $22.75 per fill, versus $53.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 26 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2023 | |||
| Orenitram ErTreprostinil Diolamine | 14 | $20,621.83 | ▼ Less than typical |
About Orenitram Er: This medication is used to treat a type of high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ Treprostinil helps to delay disease worsening and increase your ability to exercise. It works by relaxing and widening the blood vessels (arteries) in the lungs and other parts of the body so that blood can flow more easily. This medication belongs to a class of drugs known as vasodilators. In 2023, this provider wrote 14 Medicare prescriptions for Orenitram Er, about half the volume of the typical Michigan prescriber of this medication (30). Medicare paid an average of $20,621.83 per fill, versus $9,420.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2023 | |||
| Furosemide | 13 | $7.41 | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2023, this provider wrote 13 Medicare prescriptions for Furosemide, about 18% of the volume of the typical Michigan prescriber of this medication (73). Medicare paid an average of $7.41 per fill, versus $6.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| UptraviSelexipag | 12 | $22,760.55 | ▼ Less than typical |
About Uptravi: Selexipag is used to treat high blood pressure in the lungs (pulmonary arterial hypertension-PAH). Show more ▾ It is used to help slow down worsening of PAH and to decrease the chance of needing treatment in a hospital. Selexipag works by making it easier for blood to flow through the arteries in your lungs. This effect helps increase your ability to exercise. In 2023, this provider wrote 12 Medicare prescriptions for Uptravi, about a third of the volume of the typical Michigan prescriber of this medication (42). Medicare paid an average of $22,760.55 per fill, versus $21,049.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| Pirfenidone | 11 | $1,631.43▼ below MI avg | ▼ Less than typical |
About Pirfenidone: Pirfenidone is used to treat a certain lung disease called idiopathic pulmonary fibrosis (IPF). Show more ▾ This disease causes the lungs to get scarred and become stiff, making it hard to breathe. Pirfenidone may help slow down the worsening of your IPF. In 2023, this provider wrote 11 Medicare prescriptions for Pirfenidone, about half the volume of the typical Michigan prescriber of this medication (25). Medicare paid an average of $1,631.43 per fill, versus $6,783.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MI average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Ventolin HfaAlbuterol Sulfate | 11 | $76.07 | ▼ Less than typical |
About Ventolin Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 11 Medicare prescriptions for Ventolin Hfa, about a third of the volume of the typical Michigan prescriber of this medication (30). Medicare paid an average of $76.07 per fill, versus $74.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12.6 30-Day Fills standardized to 30-day supplies 324 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for SAMUEL A ALLEN D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Troy, MI practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MI prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
